Sponsor

Mylan Bertek Pharmaceuticals

Clinical research sponsor

Published trials13
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

13 shown
Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With HypertensionNCT00142584 · lead sponsor · 2005-08-01
COMPLETED
Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African AmericansNCT00145210 · lead sponsor · 2005-04-01
COMPLETED
A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or PlaceboNCT00158093 · lead sponsor · 2003-06-01
COMPLETED
A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With HypertensionNCT00200434 · lead sponsor · 2002-10-01
COMPLETED
A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate HypertensionNCT00200421 · lead sponsor · 2002-05-01
COMPLETED
A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive PatientsNCT00200499 · lead sponsor · 2002-03-01
COMPLETED
Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate HypertensionNCT00145236 · lead sponsor · 2001-11-01
COMPLETED
A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive PatientsNCT00200460 · lead sponsor · 2001-09-01
COMPLETED
A Study of the Safety and Efficacy of Nebivolol in Hypertensive PatientsNCT00200473 · lead sponsor · 2001-09-01
COMPLETED
Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons DiseaseNCT00200525 · lead sponsor · 2001-07-01
COMPLETED
A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.NCT00145171 · lead sponsor · 2001-02-01
COMPLETED
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three MonthsNCT00200512 · lead sponsor · 1999-09-01
COMPLETED
Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's DiseaseNCT00142545 · lead sponsor · 1999-07-01
COMPLETED

Sponsor roles

lead sponsor13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.